| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/SJ.EJHG.5200743 |
| P698 | PubMed publication ID | 11938437 |
| P2093 | author name string | Pascale Guicheney | |
| Valérie Allamand | |||
| P2860 | cites work | Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan | Q24535942 |
| Merosin and congenital muscular dystrophy | Q28145060 | ||
| PCR based mutation screening of the laminin alpha2 chain gene (LAMA2): application to prenatal diagnosis and search for founder effects in congenital muscular dystrophy | Q33680352 | ||
| Animal models for muscular dystrophy: valuable tools for the development of therapies | Q34045919 | ||
| Laminin alpha2 muscular dystrophy: genotype/phenotype studies of 22 patients. | Q47801479 | ||
| The Peter Emil Becker Award lecture 1998. The saga of congenital muscular dystrophy | Q48166448 | ||
| Genetic epidemiology of congenital muscular dystrophy in a sample from north-east Italy | Q71482663 | ||
| Massive muscle cell degeneration in the early stage of merosin-deficient congenital muscular dystrophy | Q73918582 | ||
| Congenital muscular dystrophy with primary partial laminin alpha2 chain deficiency: molecular study | Q74601951 | ||
| 85th ENMC International Workshop on Congenital Muscular Dystrophy. 6th International CMD Workshop. 1st Workshop of the Myo-Cluster Project 'GENRE'. 27-28th October 2000, Naarden, The Netherlands | Q77316172 | ||
| P433 | issue | 2 | |
| P921 | main subject | congenital muscular dystrophy | Q1321884 |
| congenital merosin-deficient muscular dystrophy 1A | Q5811448 | ||
| P304 | page(s) | 91-94 | |
| P577 | publication date | 2002-02-01 | |
| P1433 | published in | European Journal of Human Genetics | Q2155433 |
| P1476 | title | Merosin-deficient congenital muscular dystrophy, autosomal recessive (MDC1A, MIM#156225, LAMA2 gene coding for alpha2 chain of laminin) | |
| P478 | volume | 10 |
| Q37555754 | 212th ENMC International Workshop: Animal models of congenital muscular dystrophies, Naarden, The Netherlands, 29-31 May 2015. |
| Q49963380 | A Homozygous LAMA2 Mutation of c.818G>A Caused Partial Merosin Deficiency in a Japanese patient. |
| Q88457883 | A Qualitative Approach to Health Related Quality-of-Life in Congenital Muscular Dystrophy |
| Q92592378 | A novel de novo variant of LAMA2 contributes to merosin deficient congenital muscular dystrophy type 1A: Case report |
| Q36291506 | A novel early onset phenotype in a zebrafish model of merosin deficient congenital muscular dystrophy |
| Q54210538 | Amelioration of Muscle and Nerve Pathology in LAMA2 Muscular Dystrophy by AAV9-Mini-Agrin. |
| Q33922811 | Amelioration of laminin-alpha2-deficient congenital muscular dystrophy by somatic gene transfer of miniagrin |
| Q27332340 | Bortezomib Does Not Reduce Muscular Dystrophy in the dy2J/dy2J Mouse Model of Laminin α2 Chain-Deficient Muscular Dystrophy |
| Q91387651 | Cellular rescue in a zebrafish model of congenital muscular dystrophy type 1A |
| Q88766665 | Child with Isolated Motor Delay: Look at the Neuroimage |
| Q91906240 | Current understanding and treatment of cardiac and skeletal muscle pathology in laminin-α2 chain-deficient congenital muscular dystrophy |
| Q40556372 | Deletion of integrin α7 subunit does not aggravate the phenotype of laminin α2 chain-deficient mice |
| Q30767612 | Diagnostic approach to the congenital muscular dystrophies |
| Q24791491 | Diseased muscles that lack dystrophin or laminin-alpha2 have altered compositions and proliferation of mononuclear cell populations |
| Q42754638 | Dysregulation of matricellular proteins is an early signature of pathology in laminin-deficient muscular dystrophy |
| Q35083601 | Elimination of myostatin does not combat muscular dystrophy in dy mice but increases postnatal lethality |
| Q41592312 | Extracellular matrix microarrays to study inductive signaling for endoderm specification |
| Q89963758 | Fibrogenesis in LAMA2-Related Muscular Dystrophy Is a Central Tenet of Disease Etiology |
| Q39120926 | Highly efficient in vivo delivery of PMO into regenerating myotubes and rescue in laminin-α2 chain-null congenital muscular dystrophy mice. |
| Q33787898 | Improving Reproducibility of Phenotypic Assessments in the DyW Mouse Model of Laminin-α2 Related Congenital Muscular Dystrophy |
| Q37625936 | Inhibition of apoptosis improves outcome in a model of congenital muscular dystrophy |
| Q37411771 | Ku70 regulates Bax-mediated pathogenesis in laminin-alpha2-deficient human muscle cells and mouse models of congenital muscular dystrophy. |
| Q90584743 | LAMA2 gene mutation update: Toward a more comprehensive picture of the laminin-α2 variome and its related phenotypes |
| Q34282245 | Laminin regulates postnatal oligodendrocyte production by promoting oligodendrocyte progenitor survival in the subventricular zone |
| Q35952091 | Laminin-111 protein therapy reduces muscle pathology and improves viability of a mouse model of merosin-deficient congenital muscular dystrophy |
| Q36531788 | Laminin-211 in skeletal muscle function |
| Q42416006 | Merosin-deficient congenital muscular dystrophy with cerebral white matter changes: a clue to its diagnosis beyond infancy. |
| Q82029853 | Myopathies with early contractures |
| Q54979072 | Natural disease history of the dy2J mouse model of laminin α2 (merosin)-deficient congenital muscular dystrophy. |
| Q36462720 | New FKRP mutations causing congenital muscular dystrophy associated with mental retardation and central nervous system abnormalities. Identification of a founder mutation in Tunisian families |
| Q99554359 | Novel mutation identification and copy number variant detection via exome sequencing in congenital muscular dystrophy |
| Q37091285 | Pathology is alleviated by doxycycline in a laminin-alpha2-null model of congenital muscular dystrophy |
| Q41541570 | Pericytes Stimulate Oligodendrocyte Progenitor Cell Differentiation during CNS Remyelination |
| Q42831325 | Premature stop codons involved in muscular dystrophies show a broad spectrum of readthrough efficiencies in response to gentamicin treatment. |
| Q35201194 | Quantitative proteomic analysis reveals metabolic alterations, calcium dysregulation, and increased expression of extracellular matrix proteins in laminin α2 chain-deficient muscle |
| Q91911067 | Rare variant in LAMA2 gene causing congenital muscular dystrophy in a Sudanese family. A case report |
| Q22001192 | Skeletal muscle laminin and MDC1A: pathogenesis and treatment strategies |
| Q42468431 | The extracellular matrix protein laminin α2 regulates the maturation and function of the blood-brain barrier |
| Q24681141 | The zebrafish candyfloss mutant implicates extracellular matrix adhesion failure in laminin alpha2-deficient congenital muscular dystrophy |
Search more.